1 uct Glybera for the treatment of lipoprotein lipase deficiency.

2 s in children and adults with lysosomal acid lipase deficiency.

3 AV1) vector for the treatment of lipoprotein lipase deficiency.

4 y in children and adults with lysosomal acid lipase deficiency, an underappreciated cause of cirrhosi

5 tified mutations in LMF1 that cause combined lipase deficiency and hypertriglyceridemia in humans.

6 y's disease, Pompe's disease, lysosomal acid lipase deficiency, and five types of mucopolysaccharidos

7 l growth and emphysema during lysosomal acid lipase deficiency are partially caused by peroxisome pro

8 asts from patients with WD (a lysosomal acid lipase deficiency characterized by excessive lipid accum

9                   Mice carrying the combined lipase deficiency (cld) mutation show severe hypertrigly

10 saturation in contrast to the lysosomal acid lipase deficiency found in Wolman disease.

11 e been approved for treatment of lipoprotein lipase deficiency in Europe.

12                               Lysosomal acid lipase deficiency is a rare, autosomal recessive conditi

13                               Lysosomal acid lipase deficiency-which can be diagnosed using dry blood

14 terious mutation in LMF1 also shows combined lipase deficiency with concomitant hypertriglyceridemia